Sickle Cell Disease
📧 Sign up to get email alerts when something new happens for Sickle Cell Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Nitric Oxide to Improve Blood Flow in Sickle Cell Disease [Phase 2]
A Phase 2 clinical trial evaluating inhaled nitric oxide to improve blood flow in sickle cell anemia has completed.
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders [Phase 1]
Phase I/II trial update of Recombinant-Methionyl Human Stem Cell Factor (SCF) in adults with sickling disorders; the study is completed.
-
FDA label_change · 2007-12-21FDA Approved: EXJADE — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for EXJADE (deferasirox) by Novartis Pharmaceuticals Corporation, updating the product labeling.
-
CLINICAL_TRIALS trial_result · 2007-09-11Clinical Trial Update: A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy [Phase 3]
Phase 3 long-term safety study of senicapoc (ICA-17043) in sickle cell disease patients, with or without hydroxyurea therapy, was terminated…
-
CLINICAL_TRIALS trial_result · 2007-08-23Clinical Trial Update: Hydroxyurea in Young Children With Sickle Cell Anemia [NA]
This ClinicalTrials.gov update reports the completed study evaluating hydroxyurea in young children with sickle cell anemia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-04-11Clinical Trial Update: Quality of Life of Children With Sickle Cell Disease Who Are Getting Chronic Transfusions With a Lifeport
Clinical Trial Update on quality-of-life outcomes for children with sickle cell disease who receive chronic transfusions using a Lifeport de…
-
CLINICAL_TRIALS trial_result · 2007-04-05Clinical Trial Update: Invasive Infections in Children With Hemoglobinopathies
A completed clinical trial update examining invasive infections in children with hemoglobinopathies, including thalassemia and sickle cell a…
-
CLINICAL_TRIALS trial_result · 2006-12-25Clinical Trial Update: Prevention Of Morbidity In Sickle Cell Disease Pilot Phase [Phase 2]
This document reports a pilot Phase 2 trial intended to prevent morbidity in sickle cell anemia. No trial results or current status details …
-
FDA approval · 2006-09-19FDA Approved: DROXIA — Supplemental Application (Waylis Therapeutics LLC)
FDA approves a supplemental application for DROXIA (hydroxyurea) submitted by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2006-08-24Clinical Trial Update: Immunogenicity and Safety Study of Pneumococcal 7-Valent Conjugate Vaccine in Sickle Cell Disease Infants. [Phase 4]
A Phase 4 immunogenicity and safety study of the Pneumococcal 7-valent conjugate vaccine in infants with sickle cell disease has been termin…
-
FDA approval · 2006-08-15FDA Approved: HYDROXYUREA — Supplemental Application (Endo USA, Inc.)
The FDA approved a supplemental application for HYDROXYUREA submitted by Endo USA, Inc.
-
CLINICAL_TRIALS trial_result · 2006-06-23Clinical Trial Update: PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease [Phase 1]
Phase 1 study reporting pharmacokinetic and pharmacodynamic responses to oral L-Citrulline in patients with sickle cell disease.
-
FDA approval ·FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease
FDA approves Casgevy (exagamglogene autotemcel) as a gene therapy for young children aged 2 years and older with sickle cell disease and rec…